“…For example, studies have shown that ARV drugs are less accessible for men and children as compared to women (Baltussen et al., 2013 ; Johnson, 2012 ; Tromp et al, 2014 ). Equity in access to ART has also been examined along clinical practices of treating patients on a first-come basis as compared to treating those who are most ill or likely to benefit from treatment (Baltussen et al., 2013 ; Cleary, Mooney, & McIntyre, 2010 ; Kalanda, Makwiza, & Kemp, 2007 ; Mendelsohn, Spiegel, Schilperoord, Cornier, & Ross, 2014 ). Less commonly, HIV equity concerns have also grappled with ARV allocation on the basis of treatment adherence (Kimmel, Daniels, Betancourt, Wood, & Prosser, 2012 ) and the integration of men into home-based HIV/AIDS care (Newman, Fogarty, Makoae, & Reavely, 2011 ).…”